Radiation Oncology

Doç. Dr. Tanju Berber

Doctor and researcher İstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi İstanbul
Lung Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyRadiation Oncologysaglik.gov.trFrom source
  • Institutionİstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesisaglik.gov.trFrom source
  • Area of workLung NeoplasmsExtracted from 3 publications · Model version —From source
  • Publications32 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-4087-4760ORCIDFrom source
  • Last synchronised5 November 2026 08:55https://cemiltascioglush.saglik.gov.tr/TR-1563460/doktorlarimiz.html#tanju-berbersaglik.gov.tr

Scientific work

Publications on Lung Neoplasms

32 publications

  1. Prognostic factors and survival outcomes in older adults with extensive-stage small cell lung cancer: A multicenter retrospective cohort study

    Medicine, 2026

    DOI 10.1097/md.0000000000048711 PMID 42116366 Open-access full textSource: OpenAlex

  2. Malignant Phosphaturic Mesenchymal Tumor With Lung Metastasis

    Cureus, 2026

    DOI 10.7759/cureus.102504 PMID 41769508 Open-access full textSource: OpenAlex

  3. High Overall Performance but Limited Multidisciplinary Depth: A Cross- Sectional Evaluation of ChatGPT in Pathological Fractures of Plasma Cell Tumors

    Research Square, 2026

    DOI 10.21203/rs.3.rs-9628103/v1 Open-access full textSource: OpenAlex

  4. Unsupervised Clustering Successfully Predicts Prognosis in NSCLC Brain Metastasis Cohorts

    Diagnostics, 2025

    DOI 10.3390/diagnostics15141747 PMID 40722497 4 citations (OpenAlex) Open-access full textSource: OpenAlex

  5. Stereotactic radiosurgery vs. fractionated radiotherapy for large vestibular schwannomas: should FSRT be the preferred treatment?

    Clinical and Translational Oncology, 2024

    DOI 10.1007/s12094-024-03790-0 PMID 39676098 Source: ORCID

  6. Stereotactic Body Radiotherapy Reirradiation Is Safe in Patients With Lung Cancer With In-Field Enlarged Tumor Recurrence

    Technology in Cancer Research & Treatment, 2024

    DOI 10.1177/15330338231208616 PMID 38860536 Open-access full textSource: ORCID

  7. A multicenter retrospective analysis of patients with nasopharyngeal carcinoma treated in IMRT era from a nonendemic population: Turkish Society for Radiation Oncology Head and Neck Cancer Group Study ( TROD 01‐001)

    Head & Neck, 2023

    DOI 10.1002/hed.27333 PMID 36854873 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. The Prognostic Values of Graded Prognostic Assessment (GPA) Index In Advanced Stage NSCLC Patients With Brain Metastasis

    Turkish Journal of Clinics and Laboratory, 2023

    DOI 10.18663/tjcl.1240361 3 citations (OpenAlex) Open-access full textSource: ORCID

  9. Results of salvage treatment with CyberKnife® fractioned radiosurgery in recurrent large chordoma

    European Spine Journal, 2023

    DOI 10.1007/s00586-022-07399-1 PMID 36180739 7 citations (Europe PMC) Source: ORCID

  10. Postoperative pelvic irradiation and vaginal brachytherapy in stage II endometrial cancer

    Annals of Clinical and Analytical Medicine, 2023

    DOI 10.4328/acam.21529 Open-access full textSource: ORCID

View all 32 publications